With a strong background in healthcare investments, the fund manager has successfully executed over 30 deals across North America and Europe. Their operator-first approach emphasizes collaboration with portfolio companies to drive growth, particularly in therapeutics, diagnostics, and digital health sectors. Noteworthy exits include several high-profile IPOs that showcase their strategic acumen in navigating various investment stages. Their thematic focus on innovation and market disruption positions them as a leader in identifying transformative opportunities within the industry.